CIP2A/p90 Autoantigen Polyclonal Antibody, AbBy Fluor™ 647 Conjugated
Product Specifications
Background
Oncoprotein that inhibits PP2A and stabilizes MYC in human malignancies. Promotes anchorage-independent cell growth and tumor formation.
Synonyms
P90; CIP2A; Protein CIP2A; Cancerous inhibitor of PP2A; p90 autoantigen; KIAA1524
Gene ID
57650
Swiss Prot
Q8TCG1
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Human
Immunogen
601-700/905
Target
CIP2A/p90 Autoantigen
Clonality
Polyclonal
Isotype
IgG
Conjugation
AbBy Fluor™ 647
Source
KLH conjugated synthetic peptide derived from human CIP2A/p90 Autoantigen
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
650nm/665nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
57650
Predicted Cross Reactivity
Mouse, Rat, Dog, Cow, Rabbit
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MART-1 (Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA, Melan-A) (Biotin)
MART-1 (Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA, Melan-A) (Biotin)